Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Nautilus Biotechnology Second Quarter 2025 Earnings Conference Call.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Perceptive Advisors Joseph Edelman | 12,594,211 | $9,130,802 | 0.34% | |
2. | Cercano Management Chris Orndorff | 7,172,985 | $5,199,697 | 0.15% | |
3. | Millennium Management Israel Englander | 1,056,839 | $766,103 | +1080% | 0% |
4. | Renaissance Technologies Jim Simons | 619,906 | $449,370 | +107% | 0% |
5. | Alyeska Investment Group Anand Parekh | 253,468 | $183,739 | 0% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.77 | 15,000 | $11,488.50 | 83,000 | 2025-05-29 | Filing | |
$0.73 | 1,500 | $1,097.55 | 20,493,392 | 2025-05-12 | Filing | |
$0.73 | 12,000 | $8,787.60 | 20,491,892 | 2025-05-08 | Filing | |
$1.00 | 23,933 | $23,889.92 | 10,141,721 | 2025-03-20 | Filing | |
$0.99 | 53,300 | $53,028.17 | 10,117,788 | 2025-03-19 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.87 | 47,031 | $134,743.82 | 0 | 2024-09-23 | Filing | |
$2.85 | 35,000 | $99,869.00 | 0 | 2024-09-17 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 17,653,917 | $12,797,324 | 4.09% | |
2. | 2,485,081 | $1,801,684 | 0% | |
3. | 2,207,619 | $1,600,303 | 0.04% | |
4. | 1,457,055 | $1,056,365 | 0.04% | |
5. | 1,060,460 | $768,559 | 0.04% |